BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


September Archive 2003 - have your press release here?

TheraSci advances its Parkinson’s Disease programme

BiotechTracker: Alizyme Drug May Be Better Tolerated Than Xenical 

BioTech Stock Report today announced the release of its October 2003 issue.

Procognia and Xcellerex Sign High Speed Glycoanalysis Agreement

BioSeeker launches new report "Global structure of breast cancer R&D"

Affymetrix Launches GeneChip® AutoLoader for the GeneChip® Scanner 3000 System New 48-array GeneChip® AutoLoader gives researchers walk-away freedom 

BiotechTracker: ISIS 104838 Moves Towards Phase III 

BiotechTracker: Antisense Drug Shows Promise for Diabetes Treatment

Johnson and Johnson first customer for Affymetrix new 96-well high-throughput GeneChip array platform

BioSeeker launches new report "Novel Tumor Vaccine Approaches"

BioSeeker launches new report "The Global Structure of Prostate Cancer R&D"

The World Skin Diseases Market 2001-2008

The Gastrointestinal Market 2003: New Blockbusters and Competitive Dynamics

DOW PHARMACEUTICAL SCIENCES NAMES DAVID W. OSBORNE VICE PRESIDENT OF PRODUCT DEVELOPMENT

CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) AND GENZYME CORPORATION STRENGTHEN COLLABORATION

CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) AND DYAX CORP. FURTHER EXPAND LICENCING AGREEMENT

UK Scientists Deliver on Breakthrough Treatment for Rheumatoid Arthritis Sufferers

Bio-Rad Enhances Imaging and Gel Analysis Software With  First Ever 21 CFR Part 11 Compliance Features

INFORSENSE ANNOUNCE ORACLE EDITION OF LEADING OPEN DISCOVERY WORKFLOW SOFTWARE

NeuroNova AB announces collaboration agreement with Lundbeck A/S 

NeuroNova AB completes new round of financing

BioPortfolio Update - e-learning bioprocessing, biotechnology and pharmaceutical news, new management reports - ghrelin, kinases etc

Food Allergies: Drug makers set to capitalize?

CAMBRIDGE ANTIBODY TECHNOLOGY REPORTS EUROPEAN APPROVAL OF HUMIRA

OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2003 

Novel drug delivery systems breathe new life into therapeutic peptides

BIOWISOM ANNOUNCES ONTOLOGY LICENSE AGREEMENT WITH GLAXOSMITHKLINE

BiotechTracker: MDX-010 Begins Phase II Breast Cancer Trial 

BiotechTracker: Thalidomide Plus Temozolmide for Melanoma 

BiotechTracker: NicOx Aspirin Derivative Is Easier on the Stomach 

BiotechTracker: Liver Function Monitoring Requirement Reduces the Convenience of Exanta 

New research driving ghrelin forward as an antiobesity target Ghrelin: Pharmaceutical & Therapeutic Opportunities for the Treatment of Obesity

OXFORD BIOMEDICA AND ENTREMED ENTER AGREEMENT ON RETINOSTAT(TM) PROGRAMME

BiotechTracker: Curis Approaches the Starting Gate

Austrian plant sciences saved from "wallflower" status

GeneChip® CustomExpress™ 11-Micron Array Format Sets New Standard for Data Capacity: 61,000 Transcripts on a Single Array

BioTech Stock Report - anticipation Tularik

Paradigm Therapeutics Limited announces the appointment of Dr Barry Kenny as Commercial Director

Inpharmatica secures ADME agreement with British Biotech

BioTech Stock Report today announced the release of its September 2003 issue. 

CAMBRIDGE ANTIBODY TECHNOLOGY AND XERION PHARMACEUTICALS EXPAND ALLIANCE INTO ANTIBODY DRUG DEVELOPMENT

MICROMET, ENZON AND CAMBRIDGE ANTIBODY TECHNOLOGY SIGN CROSS-LICENCE AGREEMENT IN THE FIELD OF SINGLE-CHAIN ANTIBODIES AND PHAGE DISPLAY

CAMBRIDGE ANTIBODY TECHNOLOGY ANNOUNCES PRODUCT LICENCE AGREEMENT WITH MICROMET AG 

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC ANNOUNCES FINANCIAL RESULTS FOR THE NINE MONTHS ENDED 30 JUNE 2003

Greenpeace and FOE report on GM corn in Spain

Affymetrix shows new DNA analysis chips at BioTechnica

BiotechTracker: RNA Interference Reagents Break the Silence from Tool Companies 

BiotechTracker: Stem Cell Therapy for Parkinson Disease 

BiotechTracker Profile of Onyx 

Serono extends collaboration with Inpharmatica

November 2003 Archive

October 2003 Archive

September 2003 Archive

July/August 2003 Archive

June 2003 Archive

May 2003 Archive

March/April 2003 Archive

February 2003 Archive

January 2003 Archive

December Archive

November Archive

October Archive

September Archive

August Archive

July Archive

June Archive

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.